{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:31:09Z","timestamp":1792031469886,"version":"4.4.0"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bioorg.2025.109202","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:11:47Z","timestamp":1762272707000},"page":"109202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Targeting lung cancer utilizing smart nanoparticles: Nanomedicine meets tumor stroma"],"prefix":"10.1016","volume":"167","author":[{"given":"Fang-yu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-zhen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109202_bb0005","series-title":"Cancer Treatment and Survivorship Statistics, 2025","author":"Wagle","year":"2025"},{"key":"10.1016\/j.bioorg.2025.109202_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN","volume":"93","author":"Zhou","year":"2024","journal-title":"Cancer Epidemiol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109202_bb0015","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/jcsm.13477","article-title":"Mortality burden of pre-treatment weight loss in patients with non-small-cell lung cancer: a systematic literature review and meta-analysis","volume":"15","author":"Bonomi","year":"2024","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.bioorg.2025.109202_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102724","article-title":"Neoadjuvant EGFR-TKI therapy in non-small cell lung cancer","volume":"126","author":"Grant","year":"2024","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bioorg.2025.109202_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2024.107968","article-title":"Systematic review and network meta-analysis of lorlatinib with comparison to other anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) as first-line treatment for ALK-positive advanced non-smallcell lung cancer (NSCLC)","volume":"197","author":"Ou","year":"2024","journal-title":"Lung Cancer"},{"issue":"37","key":"10.1016\/j.bioorg.2025.109202_bb0030","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1080\/14796694.2024.2407280","article-title":"An updated overview of K-RAS G12C inhibitors in advanced stage non-small cell lung cancer","volume":"20","author":"Tenekeci","year":"2024","journal-title":"Future Oncol."},{"issue":"29","key":"10.1016\/j.bioorg.2025.109202_bb0035","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1200\/JCO.24.00553","article-title":"Sustained clinical benefit and intracranial activity of tarlatamab in previously treated small cell lung cancer: DeLLphi-300 trial update","volume":"42","author":"Dowlati","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"10459","key":"10.1016\/j.bioorg.2025.109202_bb0040","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(24)01756-2","article-title":"Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"404","author":"Spicer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2025.109202_bb0045","doi-asserted-by":"crossref","first-page":"1366260","DOI":"10.3389\/fimmu.2024.1366260","article-title":"Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges","volume":"15","author":"Xiang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0050","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/1061186X.2024.2410462","article-title":"Targeting the lung tumour stroma: harnessing nanoparticles for effective therapeutic interventions","volume":"33","author":"Zhang","year":"2025","journal-title":"J. Drug Target."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003276","article-title":"TiME for a change: the tumor microenvironment as the missing piece in cancer therapeutics","volume":"23","author":"Mo","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117049","article-title":"Stromal reprogramming: a target for tumor therapy","volume":"239","author":"Najafi","year":"2019","journal-title":"Life Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0065","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1878-0261.13146","article-title":"Dual inhibition of TGF-\u03b2 and PD-L1: a novel approach to cancer treatment","volume":"16","author":"Gulley","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0070","first-page":"1","article-title":"Targeting prostate tumour and its stroma by nanoparticles","author":"Liao","year":"2025","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109202_bb0080","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/cas.14537","article-title":"Heterogeneity of cancer-associated fibroblasts: opportunities for precision medicine","volume":"111","author":"Kanzaki","year":"2020","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0085","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.3390\/cancers12113108","article-title":"Cancer-associated fibroblasts: understanding their heterogeneity","volume":"12","author":"Louault","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109202_bb0090","first-page":"2484","article-title":"Cancer associated fibroblasts are distinguishable from peri-tumor fibroblasts by biological characteristics in TSCC","volume":"18","author":"Ba","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0095","first-page":"64","article-title":"Biomarkers for cancer-associated fibroblasts. Biomarker","volume":"8","author":"Han","year":"2020","journal-title":"Research"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109202_bb0100","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cell.2018.01.009","article-title":"CD10+ GPR77+ cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.bioorg.2025.109202_bb0105","doi-asserted-by":"crossref","first-page":"76116","DOI":"10.18632\/oncotarget.18814","article-title":"Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0110","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12931-025-03263-0","article-title":"Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion","volume":"26","author":"Cheng","year":"2025","journal-title":"Respir. Res."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109202_bb0115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3390\/cancers11091257","article-title":"PD-L1 induction by cancer-associated fibroblast-derived factors in lung adenocarcinoma cells","volume":"11","author":"Inoue","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb0120","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/ijc.32278","article-title":"Cancer-associated fibroblasts promote PD-L1 expression in mice cancer cells via secreting CXCL5","volume":"145","author":"Li","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050019","article-title":"Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting","volume":"5","author":"Pietras","year":"2008","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109202_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006244","article-title":"Reprogramming of normal fibroblasts into cancer-associated fibroblasts by miRNAs-mediated CCL2\/VEGFA signaling","volume":"12","author":"Shen","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bioorg.2025.109202_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1515390","article-title":"Interplay between cancer-associated fibroblasts and dendritic cells: implications for tumor immunity [review]","author":"Mentucci","year":"2025","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0140","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1083\/jcb.201702033","article-title":"Cancer-associated fibroblasts lead tumor invasion through integrin-\u03b23-dependent fibronectin assembly","volume":"216","author":"Attieh","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0145","article-title":"Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology","volume":"2019\/03\/06;38(1):115","author":"Nissen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109202_bb0150","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fonc.2020.00397","article-title":"Tumor microenvironment: extracellular matrix alterations influence tumor progression","volume":"10","author":"Brassart-Pasco","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3389\/fonc.2015.00165","article-title":"Overview of methods for overcoming hindrance to drug delivery to tumors, with special attention to tumor interstitial fluid","volume":"5","author":"Baronzio","year":"2015","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109202_bb0160","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41419-022-04928-0","article-title":"Integrin \u03b13\/\u03b16 and \u03b1V are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression","volume":"13","author":"Zhou","year":"2022","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109202_bb0165","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/cas.13078","article-title":"YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer","volume":"107","author":"Horie","year":"2016","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109202_bb0170","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10439-014-1167-5","article-title":"Extracellular matrix as a driver for lung regeneration","volume":"43","author":"Balestrini","year":"2015","journal-title":"Ann. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0175","doi-asserted-by":"crossref","first-page":"8678","DOI":"10.1038\/s41598-017-09062-y","article-title":"Silencing of TGF-\u03b21 in tumor cells impacts MMP-9 in tumor microenvironment","volume":"7","author":"Moore-Smith","year":"2017","journal-title":"Sci. Rep."},{"issue":"6230","key":"10.1016\/j.bioorg.2025.109202_bb0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.109202_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","article-title":"Dendritic cells in cancer: the role revisited","volume":"45","author":"Veglia","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1158\/2326-6066.CIR-17-0273","article-title":"TUSC2 immunogene therapy synergizes with anti\u2013PD-1 through enhanced proliferation and infiltration of natural killer cells in syngeneic Kras-mutant mouse lung cancer models","volume":"6","author":"Meraz","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109202_bb0195","first-page":"880","article-title":"Infiltration of CD8+ FOXP3+ T cells, CD8+ T cells, and FOXP3+ T cells in non-small cell lung cancer microenvironment","volume":"13","author":"Hao","year":"2020","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109202_bb0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","article-title":"CD4+ T cells in cancer","volume":"4","author":"Speiser","year":"2023","journal-title":"Nature cancer."},{"key":"10.1016\/j.bioorg.2025.109202_bb0205","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3389\/fonc.2019.01384","article-title":"Lung cancer heterogeneity in modulation of Th17\/IL17A responses","volume":"9","author":"Armstrong","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00262-016-1930-6","article-title":"Elevated regulatory T cells, surface and intracellular CTLA-4 expression and interleukin-17 in the lung cancer microenvironment in humans","volume":"66","author":"Kwiecien","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109202_bb0215","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.21037\/tlcr-20-1241","article-title":"A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications","volume":"10","author":"Sedighzadeh","year":"2021","journal-title":"Translational lung cancer research."},{"key":"10.1016\/j.bioorg.2025.109202_bb0220","article-title":"Clinical significance of PD-L1 protein expression on tumor-associated macrophages in lung cancer. Journal for ImmunoTherapy of","volume":"2015\/11\/04;3(2):P415","author":"Schalper","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0211041","article-title":"Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: a mathematical model","volume":"14","author":"Kim","year":"2019","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0230","doi-asserted-by":"crossref","first-page":"12988","DOI":"10.1038\/s41598-025-97556-5","article-title":"MiR-150 deletion promotes lung tumor growth by upregulating P-STAT3 and ROS in MDSCs","volume":"15","author":"Qin","year":"2025","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/14737140.2022.2019018","article-title":"Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer","volume":"22","author":"Suzuki","year":"2022","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bioorg.2025.109202_bb0240","doi-asserted-by":"crossref","first-page":"1367875","DOI":"10.3389\/fimmu.2024.1367875","article-title":"Endothelial cells in tumor microenvironment: insights and perspectives","volume":"15","author":"Leone","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109202_bb0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41419-020-2511-3","article-title":"Anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109202_bb0250","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/cas.13336","article-title":"Tumor endothelial cells accelerate tumor metastasis","volume":"108","author":"Maishi","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2025.109202_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216074","article-title":"Pericytes in the tumor microenvironment","volume":"556","author":"Jiang","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0260","first-page":"5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1568009622666211224154952","article-title":"Role of tumor microenvironment in cancer stem cells resistance to radiotherapy","volume":"22","author":"Taeb","year":"2022","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bioorg.2025.109202_bb0270","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.phrs.2019.02.027","article-title":"Targeting the crosstalks of Wnt pathway with hedgehog and notch for cancer therapy","volume":"142","author":"Chatterjee","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109202_bb0275","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/sctm.17-0138","article-title":"Concise review: cancer cells, cancer stem cells, and mesenchymal stem cells: influence in cancer development","volume":"6","author":"Papaccio","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109202_bb0280","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.imbio.2013.11.004","article-title":"Lung cancer neovascularisation: cellular and molecular interaction between endothelial and lung cancer cells","volume":"219","author":"Kaessmeyer","year":"2014","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109202_bb0285","doi-asserted-by":"crossref","first-page":"2200046","DOI":"10.1002\/adbi.202200046","article-title":"The role of nerve fibers in the tumor immune microenvironment of solid tumors","volume":"6","author":"Hernandez","year":"2022","journal-title":"Advanced Biology."},{"key":"10.1016\/j.bioorg.2025.109202_bb0290","doi-asserted-by":"crossref","first-page":"1360471","DOI":"10.3389\/fonc.2024.1360471","article-title":"Bone marrow adipocytes and lung cancer bone metastasis: unraveling the role of adipokines in the tumor microenvironment","volume":"14","author":"Li","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0295","article-title":"Acute vs. chronic vs. cyclic hypoxia: their differential dynamics, molecular mechanisms, and effects on tumor progression","volume":"9(8):339","author":"Saxena","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.109202_bb0300","first-page":"253","article-title":"Progress toward overcoming hypoxia-induced resistance to solid tumor therapy","author":"Karakashev","year":"2015","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cells8010045","article-title":"HIF-1\u03b1 and HIF-2\u03b1 differently regulate the radiation sensitivity of NSCLC cells","volume":"8","author":"Moreno Roig","year":"2019","journal-title":"Cells"},{"issue":"13","key":"10.1016\/j.bioorg.2025.109202_bb0310","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.18632\/aging.204826","article-title":"PRMT5 facilitates angiogenesis and EMT via HIF-1\u03b1\/VEGFR\/Akt signaling axis in lung cancer","volume":"15","author":"Zheng","year":"2023","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"17","key":"10.1016\/j.bioorg.2025.109202_bb0320","doi-asserted-by":"crossref","first-page":"23141","DOI":"10.18632\/oncotarget.8153","article-title":"The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2025.109202_bb0325","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fonc.2018.00081","article-title":"Metabolic symbiosis and immunomodulation: how tumor cell-derived lactate may disturb innate and adaptive immune responses","volume":"8","author":"Morrot","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0330","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s40001-024-01780-0","article-title":"Photodynamic therapy upregulates expression of HIF-1\u03b1 and PD-L1 in related pathways and its clinical relevance in non-small-cell lung cancer","volume":"29","author":"Sun","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187314","article-title":"Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells","volume":"12","author":"Sethumadhavan","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.bioorg.2025.109202_bb0340","series-title":"Endothelial Cells in the Tumor Microenvironment","first-page":"71","author":"Sobierajska","year":"2020"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0345","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12951-021-01221-8","article-title":"Charge reversal nano-systems for tumor therapy","volume":"20","author":"Zhang","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109202_bb0350","doi-asserted-by":"crossref","first-page":"1800917","DOI":"10.1002\/marc.201800917","article-title":"pH-responsive polymer nanoparticles for drug delivery","volume":"40","author":"Deirram","year":"2019","journal-title":"Macromol. Rapid Commun."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109202_bb0355","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.tips.2018.06.003","article-title":"MMP-responsive \u2018smart\u2019drug delivery and tumor targeting","volume":"39","author":"Yao","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bioorg.2025.109202_bb0360","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.actbio.2023.09.037","article-title":"Redox-active polyphenol nanoparticles deprive endogenous glutathione of electrons for ROS generation and tumor chemodynamic therapy","volume":"172","author":"Wang","year":"2023","journal-title":"Acta Biomater."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.nano.2012.07.002","article-title":"Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure","volume":"9","author":"Torosean","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.109202_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2022.100364","article-title":"Tumor extracellular matrix modulating strategies for enhanced antitumor therapy of nanomedicines","volume":"16","author":"Li","year":"2022","journal-title":"Materials Today Bio."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb0375","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s12094-024-03793-x","article-title":"Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles","volume":"27","author":"Muhammad","year":"2025","journal-title":"Clinical and Translational Oncology."},{"key":"10.1016\/j.bioorg.2025.109202_bb0380","article-title":"Improving cancer immunotherapy: exploring and targeting metabolism in hypoxia microenvironment","volume":"13","author":"Wei","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0385","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsps.2017.10.012","article-title":"Applications of nanoparticle systems in drug delivery technology","volume":"26","author":"Rizvi","year":"2018","journal-title":"Saudi pharmaceutical journal."},{"key":"10.1016\/j.bioorg.2025.109202_bb0390","doi-asserted-by":"crossref","first-page":"1154318","DOI":"10.3389\/fonc.2023.1154318","article-title":"The use of nanoparticles for targeted drug delivery in non-small cell lung cancer","volume":"13","author":"Holder","year":"2023","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0395","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12951-022-01539-x","article-title":"Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems","volume":"20","author":"Subramanian","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109202_bb0400","doi-asserted-by":"crossref","first-page":"8689","DOI":"10.1021\/acsnano.5b02028","article-title":"Remodeling tumor vasculature to enhance delivery of intermediate-sized nanoparticles","volume":"9","author":"Jiang","year":"2015","journal-title":"ACS Nano"},{"issue":"34","key":"10.1016\/j.bioorg.2025.109202_bb0405","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1002\/smll.201501034","article-title":"Pulmonary codelivery of doxorubicin and siRNA by pH-sensitive nanoparticles for therapy of metastatic lung cancer","volume":"11","author":"Xu","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.bioorg.2025.109202_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109861","article-title":"Non-small cell lung cancer combination therapy: hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab","volume":"125","author":"Pang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109202_bb0415","doi-asserted-by":"crossref","first-page":"2202063","DOI":"10.1002\/adhm.202202063","article-title":"Smart nanoparticle-based platforms for regulating tumor microenvironment and cancer immunotherapy","volume":"12","author":"Cheng","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioorg.2025.109202_bb0420","article-title":"Lipid nanoparticles for drug delivery. Advanced NanoBiomed","volume":"2022\/02\/01;2(2):2100109","author":"Xu","year":"2022","journal-title":"Research"},{"key":"10.1016\/j.bioorg.2025.109202_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.601626","article-title":"Biodegradable polymeric nanoparticles for drug delivery to solid tumors","volume":"12","author":"Gagliardi","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0430","article-title":"Inorganic nanoparticles: a potential cancer therapy for human welfare","volume":"2018\/03\/25\/;539(1):104-111","author":"Pugazhendhi","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb0435","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1080\/17425247.2016.1229298","article-title":"Recent advances in porous nanoparticles for drug delivery in antitumoral applications: inorganic nanoparticles and nanoscale metal-organic frameworks","volume":"14","author":"Baeza","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109202_bb0440","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1021\/acs.bioconjchem.9b00456","article-title":"Insights into active targeting of nanoparticles in drug delivery: advances in clinical studies and design considerations for cancer nanomedicine","volume":"30","author":"Pearce","year":"2019","journal-title":"Bioconjug. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109202_bb0445","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1389200217666160619191853","article-title":"Actively targeted nanoparticles for drug delivery to tumor","volume":"17","author":"Bi","year":"2016","journal-title":"Curr. Drug Metab."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109202_bb0450","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.bmcl.2018.07.012","article-title":"Effective cancer therapy based on selective drug delivery into cells across their membrane using receptor-mediated endocytosis","volume":"28","author":"Tashima","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109202_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.610533","article-title":"Tumor microenvironment-stimuli responsive nanoparticles for anticancer therapy","volume":"7","author":"Thomas","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bioorg.2025.109202_bb0460","article-title":"Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes","volume":"2405-2426","author":"Jin","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.109202_bb0465","series-title":"pH-Responsive Materials: Properties, Design, and Applications","first-page":"145","author":"Patra","year":"2023"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109202_bb0470","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00396-020-04606-7","article-title":"pH-responsive nanoparticles based on optimized synthetic amphiphilic poly (\u03b2-amino esters) for doxorubicin delivery","volume":"298","author":"Gao","year":"2020","journal-title":"Colloid Polym. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0475","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1039\/C8TB02360C","article-title":"A pH-responsive self-healing hydrogel based on multivalent coordination of Ni 2+ with polyhistidine-terminated PEG and IDA-modified oligochitosan","volume":"7","author":"Tang","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb0480","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/adhm.201400736","article-title":"pH-responsive reversible PEGylation improves performance of antineoplastic agent","volume":"4","author":"Sun","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioorg.2025.109202_bb0485","article-title":"Matrix metalloproteinase 2\/9-triggered-release micelles for inhaled drug delivery to treat lung cancer: preparation and in vitro\/in vivo studies","volume":"4641-4659","author":"Wang","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.109202_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121806","article-title":"Comparative study of cathepsin B-cleavable linkers for the optimal design of cathepsin B-specific doxorubicin prodrug nanoparticles for targeted cancer therapy","volume":"289","author":"Shim","year":"2022","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.bioorg.2025.109202_bb0495","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1039\/D3BM00840A","article-title":"MMP-responsive nanomaterials","volume":"11","author":"Son","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioorg.2025.109202_bb0500","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2018.03.011","article-title":"Enhanced uptake in 2D-and 3D-lung cancer cell models of redox responsive PEGylated nanoparticles with sensitivity to reducing extra-and intracellular environments","volume":"277","author":"Conte","year":"2018","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0505","doi-asserted-by":"crossref","first-page":"12452","DOI":"10.1021\/acsanm.4c00826","article-title":"Hypoxia-responsive nanomicelle based on 2-nitroimidazole for tumor treatment through chemotherapy and modulation of the tumor redox microenvironment","volume":"7","author":"Zhu","year":"2024","journal-title":"ACS Applied Nano Materials."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0510","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s13369-022-07156-y","article-title":"Synthesis and characterization of novel nano azo compounds as a new pH sensor","volume":"48","author":"Abbas","year":"2023","journal-title":"Arab. J. Sci. Eng."},{"key":"10.1016\/j.bioorg.2025.109202_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2023.100722","article-title":"Tumor-overexpressed enzyme responsive amphiphiles small molecular self-assembly nano-prodrug for the chemo-phototherapy against non-small-cell lung cancer","volume":"21","author":"Liu","year":"2023","journal-title":"Materials Today Bio."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109202_bb0520","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3390\/ma15041606","article-title":"Photothermal and photodynamic therapy of tumors with plasmonic nanoparticles: challenges and prospects","volume":"15","author":"Bucharskaya","year":"2022","journal-title":"Materials"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0525","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/nano5010063","article-title":"Magnetic properties of magnetic nanoparticles for efficient hyperthermia","volume":"5","author":"Obaidat","year":"2015","journal-title":"Nanomaterials"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109202_bb0530","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/polym8100359","article-title":"A review of Thermo- and ultrasound-responsive polymeric Systems for Delivery of chemotherapeutic agents","volume":"8","author":"Zardad","year":"2016","journal-title":"Polymers"},{"key":"10.1016\/j.bioorg.2025.109202_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2020.12.011","article-title":"pH-sensitive multi-drug liposomes targeting folate receptor \u03b2 for efficient treatment of non-small cell lung cancer","author":"Park","year":"2021","journal-title":"J. Control. Release"},{"issue":"42","key":"10.1016\/j.bioorg.2025.109202_bb0540","doi-asserted-by":"crossref","first-page":"8768","DOI":"10.1039\/D1TB01619A","article-title":"A pH-sensitive T7 peptide-decorated liposome system for HER2 inhibitor extracellular delivery: an application for the efficient suppression of HER2+ breast cancer","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0545","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2217\/nnm-2020-0022","article-title":"pH-responsive PEG-chitosan\/iron oxide hybrid nanoassemblies for low-power assisted PDT\/PTT combination therapy","volume":"15","author":"Zhang","year":"2020","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.bioorg.2025.109202_bb0550","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ultsonch.2017.04.025","article-title":"Ultrasound-assisted synthesis of pH-responsive nanovector based on PEG\/chitosan coated magnetite nanoparticles for 5-FU delivery","volume":"39","author":"Khoee","year":"2017","journal-title":"Ultrason. Sonochem."},{"key":"10.1016\/j.bioorg.2025.109202_bb0555","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.2147\/IJN.S436253","article-title":"A novel pH-responsive Iron oxide Core-Shell magnetic mesoporous silica nanoparticle (M-MSN) system encapsulating doxorubicin (DOX) and glucose oxidase (Gox) for pancreatic Cancer treatment","volume":"18","author":"Qi","year":"2023","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109202_bb0560","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/acsbiomaterials.9b00099","article-title":"Super-pH-sensitive mesoporous silica nanoparticle-based drug delivery system for effective combination Cancer therapy","volume":"5","author":"Cheng","year":"2019","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.bioorg.2025.109202_bb0565","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.msec.2017.08.036","article-title":"pH and redox dual stimulate-responsive nanocarriers based on hyaluronic acid coated mesoporous silica for targeted drug delivery","volume":"C","author":"Lin","year":"2017","journal-title":"Mater. Sci. Eng."},{"key":"10.1016\/j.bioorg.2025.109202_bb0570","article-title":"Redox and pH-responsive gold nanoparticles as a new platform for simultaneous triple anti-cancer drugs targeting","volume":"2017\/03\/30\/;520(1):126-138","author":"Ghorbani","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.109202_bb0575","article-title":"Dual pH-responsive \u201ccharge-reversal like\u201d gold nanoparticles to enhance tumor retention for chemo-radiotherapy","volume":"2019\/11\/01;12(11):2815-2826","author":"Zhang","year":"2019","journal-title":"Nano Res"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109202_bb0580","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1039\/D1NA00116G","article-title":"Hyperthermia-mediated changes in the tumor immune microenvironment using iron oxide nanoparticles","volume":"3","author":"Covarrubias","year":"2021","journal-title":"Nanoscale Adv."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0585","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1021\/acsnano.5b07249","article-title":"Duality of Iron oxide nanoparticles in Cancer therapy: amplification of heating efficiency by magnetic hyperthermia and Photothermal bimodal treatment","volume":"10","author":"Espinosa","year":"2016","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb0590","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1571","article-title":"Use of magnetic fields and nanoparticles to trigger drug release and improve tumor targeting","author":"Liu","year":"2019","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0595","article-title":"pH-Responsive Metal\u2013Organic Framework-Coated Mesoporous Silica Nanoparticles for Immunotherapy","volume":"2021\/12\/24;4(12):13398-13404","author":"Duan","year":"2021","journal-title":"ACS Applied Nano Materials."},{"issue":"37","key":"10.1016\/j.bioorg.2025.109202_bb0600","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1039\/D0TB01021A","article-title":"MOF-derived novel porous Fe3O4@C nanocomposites as smart nanomedical platforms for combined cancer therapy: magnetic-triggered synergistic hyperthermia and chemotherapy [10.1039\/D0TB01021A]","volume":"8","author":"Xiang","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bioorg.2025.109202_bb0605","article-title":"Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release","volume":"2019\/12\/31;20(1):1043-1054","author":"Chen","year":"2019","journal-title":"Sci. Technol. Adv. Mater."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb0610","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.trecan.2022.03.001","article-title":"Targeting CAFs to overcome anticancer therapeutic resistance","volume":"8","author":"Saw","year":"2022","journal-title":"Trends Cancer."},{"key":"10.1016\/j.bioorg.2025.109202_bb0615","article-title":"The application of nanoparticles targeting Cancer-associated fibroblasts","volume":"2024\/12\/31;19(null):3333-3365","author":"Huang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0620","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192157","article-title":"Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer","volume":"13","author":"Kilvaer","year":"2018","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202007017","article-title":"FAP-targeted photodynamic therapy mediated by ferritin nanoparticles elicits an immune response against Cancer cells and Cancer associated fibroblasts","volume":"31","author":"Zhou","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioorg.2025.109202_bb0630","article-title":"Protein Nanocage mediated fibroblast-activation protein targeted Photoimmunotherapy to enhance cytotoxic T cell infiltration and tumor control","volume":"2017\/02\/08;17(2):862-869","author":"Zhen","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioorg.2025.109202_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113998","article-title":"Cancer-associated fibroblast-derived extracellular vesicles loaded with GLUT1 inhibitor synergize anti-PD-L1 to suppress tumor growth via degrading matrix stiffness and remodeling tumor microenvironment","author":"Wu","year":"2025","journal-title":"J. Control. Release"},{"issue":"17","key":"10.1016\/j.bioorg.2025.109202_bb0640","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.2174\/13816128113199990592","article-title":"PDGF\/PDGFR signaling and targeting in cancer growth and progression: focus on tumor microenvironment and cancer-associated fibroblasts","volume":"20","author":"Gialeli","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2025.109202_bb0645","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.3389\/fonc.2020.01766","article-title":"The role of the ECM in lung cancer dormancy and outgrowth","volume":"10","author":"Parker","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb0650","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/08941939.2019.1672839","article-title":"COL11A1 was involved in cell proliferation, apoptosis and migration in non-small cell lung cancer cells","volume":"34","author":"Tu","year":"2021","journal-title":"J. Invest. Surg."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0655","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bjc.6605154","article-title":"Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion","volume":"101","author":"Meng","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0660","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.3390\/ijms19113674","article-title":"YAP\/TAZ signaling as a molecular link between fibrosis and cancer","volume":"19","author":"Noguchi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109202_bb0665","article-title":"Targeting breast tumor extracellular matrix and stroma utilizing nanoparticles","volume":"1-24","author":"Muhammad","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114512","article-title":"Inhalable nano-structured microparticles for extracellular matrix modulation as a potential delivery system for lung cancer","author":"Abdel-Hafez","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioorg.2025.109202_bb0675","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2017.02.035","article-title":"Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound","author":"Lee","year":"2017","journal-title":"J. Control. Release"},{"issue":"20","key":"10.1016\/j.bioorg.2025.109202_bb0680","doi-asserted-by":"crossref","first-page":"9402","DOI":"10.1039\/D1NR00950H","article-title":"Collagenase-loaded pH-sensitive nanocarriers efficiently remodeled tumor stroma matrixes and improved the enrichment of nanomedicines","volume":"13","author":"Wang","year":"2021","journal-title":"Nanoscale"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109202_bb0685","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.3390\/cancers15123076","article-title":"Cancer cell-intrinsic alterations associated with an immunosuppressive tumor microenvironment and resistance to immunotherapy in lung cancer","volume":"15","author":"Otegui","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0690","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","article-title":"Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment","volume":"12","author":"Yang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"14","key":"10.1016\/j.bioorg.2025.109202_bb0695","doi-asserted-by":"crossref","first-page":"7072","DOI":"10.7150\/thno.57803","article-title":"An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment","volume":"11","author":"Hsieh","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0700","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2217\/nnm-2019-0190","article-title":"Depleting tumor-associated Tregs via nanoparticle-mediated hyperthermia to enhance anti-CTLA-4 immunotherapy","volume":"15","author":"Chen","year":"2020","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.bioorg.2025.109202_bb0705","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.2147\/IJN.S346341","article-title":"Engineered hybrid Treg-targeted Nanosomes restrain lung immunosuppression by inducing Intratumoral CD8(+)T cell immunity","volume":"17","author":"Domvri","year":"2022","journal-title":"Int. J. Nanomedicine"},{"issue":"13","key":"10.1016\/j.bioorg.2025.109202_bb0710","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.1039\/D0NR00080A","article-title":"Dual photothermal MDSCs-targeted immunotherapy inhibits lung immunosuppressive metastasis by enhancing T-cell recruitment","volume":"12","author":"Domvri","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.bioorg.2025.109202_bb0715","doi-asserted-by":"crossref","first-page":"11087","DOI":"10.2147\/IJN.S472796","article-title":"Unexpected inhibitory role of silica nanoparticles on lung Cancer development by promoting M1 polarization of macrophages","volume":"19","author":"Xiang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.109202_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122955","article-title":"Pulmonary delivery of dual-targeted nanoparticles improves tumor accumulation and cancer cell targeting by restricting macrophage interception in orthotopic lung tumors","author":"Ge","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioorg.2025.109202_bb0725","article-title":"Ultrasound-responsive Nanocarriers delivering siRNA and Fe3O4 nanoparticles reprogram macrophages and inhibit M2 polarization for enhanced NSCLC immunotherapy","volume":"2024\/10\/23;16(42):56634-56652","author":"Li","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioorg.2025.109202_bb0730","article-title":"Autologous nanovaccine repolarizes tumor-associated macrophages to M1 phenotype inducing PANoptosis for lung cancer immunotherapy","author":"Zhang","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb0735","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1021\/acs.nanolett.8b00689","article-title":"Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating microRNA-125b","volume":"18","author":"Parayath","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.bioorg.2025.109202_bb0740","article-title":"Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues","volume":"2016\/11\/01;11(11):986-994","author":"Zanganeh","year":"2016","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0745","article-title":"Dual-targeting tumor cells and tumor associated macrophages with lipid coated calcium zoledronate for enhanced lung cancer chemoimmunotherapy","author":"Zang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.109202_bb0750","article-title":"Endocytic programming via porous silicon nanoparticles enhances TLR4 Nanoagonist potency for macrophage-mediated immunotherapy","author":"Zhang","year":"2025","journal-title":"Adv. Funct. Mater."},{"issue":"44","key":"10.1016\/j.bioorg.2025.109202_bb0755","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304966120","article-title":"Inhaled mRNA nanoparticles dual-targeting cancer cells and macrophages in the lung for effective transfection","volume":"120","author":"Tang","year":"2023","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"329","key":"10.1016\/j.bioorg.2025.109202_bb0760","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jconrel.2020.10.052","article-title":"Biomimetic codelivery overcomes osimertinib-resistant NSCLC and brain metastasis via macrophage-mediated innate immunity","volume":"10","author":"Zhao","year":"2021","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0765","article-title":"Tumor-induced CD8+ T-cell dysfunction in lung cancer patients","volume":"2012","author":"Prado-Garcia","year":"2012","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bioorg.2025.109202_bb0770","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8+ T cell exhaustion in cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109202_bb0775","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3390\/jcm9051362","article-title":"Immune checkpoint inhibitors for lung cancer treatment: a review","volume":"9","author":"Onoi","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109202_bb0780","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002780","article-title":"Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer","volume":"9","author":"Kim","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109202_bb0785","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/08830185.2024.2333275","article-title":"Boosting immune responses in lung tumor immune microenvironment: a comprehensive review of strategies and adjuvants","volume":"43","author":"Gao","year":"2024","journal-title":"Int. Rev. Immunol."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109202_bb0790","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.3390\/cells12192404","article-title":"Dendritic cell vaccination in non-small cell lung cancer: remodeling the tumor immune microenvironment","volume":"12","author":"Abascal","year":"2023","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0795","doi-asserted-by":"crossref","DOI":"10.1093\/cei\/uxae110","article-title":"Intratumoral injection of R848 and poly(I:C) synergistically promoted antitumor immune responses by reprogramming macrophage polarization and activating DCs in lung cancer","volume":"219","author":"Chen","year":"2025","journal-title":"Clin. Exp. Immunol."},{"issue":"600","key":"10.1016\/j.bioorg.2025.109202_bb0800","article-title":"Encapsulation of a CpG oligonucleotide in cationic liposomes enhances its local antitumor activity following pulmonary delivery in a murine model of metastatic lung cancer","volume":"1","author":"Loira-Pastoriza","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.109202_bb0805","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.intimp.2018.11.019","article-title":"Preclinical development of the TLR9 agonist DV281 as an inhaled aerosolized immunotherapeutic for lung cancer: pharmacological profile in mice, non-human primates, and human primary cells","volume":"66","author":"Kell","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2022.5449","article-title":"The TLR7\/8 agonist R848 optimizes host and tumor immunity to improve therapeutic efficacy in murine lung cancer","volume":"61","author":"Zhou","year":"2022","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0815","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/COC.0000000000000239","article-title":"CTLA-4 and PD-1 pathways: similarities, differences, and implications of their inhibition","volume":"39","author":"Buchbinder","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109202_bb0820","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007502","article-title":"Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic fc-active TIGIT antibodies","volume":"11","author":"Hasan","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109202_bb0825","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jtho.2017.01.019","article-title":"LAG-3 protein expression in non\u2013small cell lung cancer and its relationship with PD-1\/PD-L1 and tumor-infiltrating lymphocytes","volume":"12","author":"He","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0830","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.2147\/OTT.S170385","article-title":"TIM-3, a promising target for cancer immunotherapy","author":"He","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bioorg.2025.109202_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217241","article-title":"Immune checkpoint inhibitors rechallenge in non-small cell lung cancer: current evidence and future directions","volume":"604","author":"Gang","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0840","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.109202_bb0845","article-title":"Immune-related adverse events of immune checkpoint inhibitors","volume":"177(2):ITC17-ITC32","author":"Ramos-Casals","year":"2024","journal-title":"Ann. Intern. Med."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0850","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.7150\/thno.112475","article-title":"Nano drug delivery systems for advanced immune checkpoint blockade therapy","volume":"15","author":"Guo","year":"2025","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0855","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12094-024-03577-3","article-title":"Shifting cold to hot tumors by nanoparticle-loaded drugs and products","volume":"27","author":"Ahmad","year":"2025","journal-title":"Clinical and Translational Oncology."},{"key":"10.1016\/j.bioorg.2025.109202_bb0860","doi-asserted-by":"crossref","first-page":"1022011","DOI":"10.3389\/fimmu.2022.1022011","article-title":"NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model","volume":"13","author":"Hu","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109202_bb0865","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijrobp.2021.06.041","article-title":"Radiation therapy enhanced by NBTXR3 nanoparticles overcomes anti-PD1 resistance and evokes Abscopal effects","volume":"111","author":"Hu","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0870","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12951-021-01163-1","article-title":"A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model","volume":"19","author":"Hu","year":"2021","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.bioorg.2025.109202_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102415","article-title":"Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7\/8 agonist in lung cancer model","author":"Koh","year":"2021","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine."},{"key":"10.1016\/j.bioorg.2025.109202_bb0880","article-title":"A novel anti-CD47 protein antibody and toll-like receptor agonist complex detects tumor surface CD-47 changes in early stage lung cancer by in vivo imaging","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0885","article-title":"TLR7\/8 agonist-loaded nanoparticles augment NK cell-mediated antibody-based Cancer immunotherapy","volume":"2020\/06\/01;17(6):2109-2124","author":"Kim","year":"2020","journal-title":"Mol. Pharm."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109202_bb0890","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003132","article-title":"Self-assembly nanovaccine containing TLR7\/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response","volume":"9","author":"Zhang","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bioorg.2025.109202_bb0895","article-title":"High-capacity poly(2-oxazoline) formulation of TLR 7\/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma","volume":"6(25):eaba5542","author":"Vinod","year":"2020","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb0900","doi-asserted-by":"crossref","first-page":"7200","DOI":"10.1021\/acsnano.0c02207","article-title":"Pulmonary delivery of nanoparticle-bound toll-like receptor 9 agonist for the treatment of metastatic lung Cancer","volume":"14","author":"Perry","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioorg.2025.109202_bb0905","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020445","article-title":"Nasal tumor vaccination protects against lung tumor development by induction of resident effector and memory anti-tumor immune responses","author":"Donkor","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0910","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1186\/s12951-022-01621-4","article-title":"Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer","volume":"20","author":"Hu","year":"2022","journal-title":"J Nanobiotechnology."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb0915","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3390\/gels10060352","article-title":"Enhancing effector Jurkat cell activity and increasing cytotoxicity against A549 cells using Nivolumab as an anti-PD-1 agent loaded on gelatin nanoparticles","volume":"10","author":"Ali","year":"2024","journal-title":"Gels"},{"key":"10.1016\/j.bioorg.2025.109202_bb0920","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.2147\/IJN.S518427","article-title":"Photothermal therapeutic gold nanoparticles loaded with PD-L1 siRNA enhanced killing of NSCLC cells by immune cells","volume":"20","author":"Gao","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb0925","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.7150\/thno.41077","article-title":"One-pot synthesis of a microporous organosilica-coated cisplatin nanoplatform for HIF-1-targeted combination cancer therapy","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109202_bb0930","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/1567201814666171019104002","article-title":"Polymeric nano-encapsulation of curcumin enhances its anti-cancer activity in breast (MDA-MB231) and lung (A549) cancer cells through reduction in expression of HIF-1\u03b1 and nuclear p65 (REL a)","volume":"15","author":"Khan","year":"2018","journal-title":"Curr. Drug Deliv."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109202_bb0935","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1039\/D1BM00284H","article-title":"An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer","volume":"9","author":"Luo","year":"2021","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.bioorg.2025.109202_bb0940","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.08.030","article-title":"Co-delivery of oxygen and erlotinib by aptamer-modified liposomal complexes to reverse hypoxia-induced drug resistance in lung cancer","volume":"145","author":"Li","year":"2017","journal-title":"Biomaterials"},{"issue":"18","key":"10.1016\/j.bioorg.2025.109202_bb0945","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3390\/nano12183138","article-title":"Biomineralized manganese oxide nanoparticles synergistically relieve tumor hypoxia and activate immune response with radiotherapy in non-small cell lung Cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Nanomaterials"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0950","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12951-023-02196-4","article-title":"Synergistic cerium oxide nanozymes: targeting DNA damage and alleviating tumor hypoxia for improved NSCLC radiotherapy efficiency","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bioorg.2025.109202_bb0955","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cbi.2016.06.006","article-title":"Transition metal oxide nanoparticles are effective in inhibiting lung cancer cell survival in the hypoxic tumor microenvironment","volume":"254","author":"Pandey","year":"2016","journal-title":"Chem. Biol. Interact."},{"issue":"21","key":"10.1016\/j.bioorg.2025.109202_bb0960","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1039\/D1NR01155C","article-title":"In situ injection of dual-delivery PEG based MMP-2 sensitive hydrogels for enhanced tumor penetration and chemo-immune combination therapy","volume":"13","author":"Yan","year":"2021","journal-title":"Nanoscale"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0965","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/10717544.2021.1931560","article-title":"A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids","volume":"28","author":"Wen","year":"2021","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0970","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1021\/acsomega.3c06489","article-title":"Short antiangiogenic MMP-2 peptide-decorated conjugated linoleic acid-coated SPIONs for targeted paclitaxel delivery in an A549 cell xenograft mouse tumor model","volume":"9","author":"Ngema","year":"2024","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0975","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/acsabm.8b00633","article-title":"Identifying a membrane-type 2 matrix metalloproteinase-targeting peptide for human lung Cancer detection and targeting chemotherapy with functionalized mesoporous silica","volume":"2","author":"Ren","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bioorg.2025.109202_bb0980","article-title":"Non-pore dependent and MMP-9 responsive gelatin\/silk fibroin composite microparticles as universal delivery platform for inhaled treatment of lung Cancer","volume":"2023\/10\/01;35(42):2303718","author":"Gou","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioorg.2025.109202_bb0985","article-title":"Design of pH-responsive nanomaterials based on the tumor microenvironment","volume":"705-721","author":"Liu","year":"2025","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109202_bb0990","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12645-022-00111-4","article-title":"Construction of pH-responsive nanocarriers in combination with ferroptosis and chemotherapy for treatment of hepatocellular carcinoma","volume":"13","author":"Yue","year":"2022","journal-title":"Cancer Nanotechnol."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb0995","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1021\/acs.molpharmaceut.7b00584","article-title":"Nanoparticles of pH-responsive, PEG\u2013doxorubicin conjugates: interaction with an in vitro model of lung adenocarcinoma and their direct formulation in propellant-based portable inhalers","volume":"14","author":"Rao","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioorg.2025.109202_bb1000","doi-asserted-by":"crossref","first-page":"108614","DOI":"10.1016\/j.biopha.2019.108614","article-title":"Lung cancer therapy using doxorubicin and curcumin combination: targeted prodrug based, pH sensitive nanomedicine","volume":"112","author":"Hong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.109202_bb1005","article-title":"Doxorubicin-loaded, pH-sensitive albumin nanoparticles for lung Cancer cell targeting","volume":"2022\/04\/01\/;111(4):1187-1196","author":"Aziz","year":"2022","journal-title":"J. Pharm. Sci."},{"issue":"18","key":"10.1016\/j.bioorg.2025.109202_bb1010","doi-asserted-by":"crossref","first-page":"1807677","DOI":"10.1002\/adfm.201807677","article-title":"Lung-endothelium-targeted nanoparticles based on a pH-sensitive lipid and the GALA peptide enable robust gene silencing and the regression of metastatic lung cancer","volume":"29","author":"Abd Elwakil","year":"2019","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioorg.2025.109202_bb1015","article-title":"Erythrocyte membrane-wrapped pH sensitive polymeric nanoparticles for non-small cell lung Cancer therapy","volume":"2017\/01\/01\/;28(10):2591-2598","author":"Gao","year":"2017","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bioorg.2025.109202_bb1020","article-title":"Nanoscaled poly(l-glutamic acid)\/doxorubicin-Amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung Cancer","volume":"2013\/03\/13;5(5):1781-1792","author":"Li","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioorg.2025.109202_bb1025","first-page":"6773","article-title":"Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy","volume":"10","author":"Amreddy","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.109202_bb1030","doi-asserted-by":"crossref","first-page":"101582","DOI":"10.1016\/j.nantod.2022.101582","article-title":"An acid degradable, lactate oxidizing nanoparticle formulation for non-small cell lung cancer virotherapy","volume":"46","author":"Tseng","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.bioorg.2025.109202_bb1035","article-title":"Lung cancer chemotherapy using nanoparticles: enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109202_bb1040","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s00432-021-03701-8","article-title":"Targeting tumor vascularization: promising strategies for vascular normalization","volume":"147","author":"Zheng","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2025.109202_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2024.105660","article-title":"Targeting hypoxic and acidic tumor microenvironment by nanoparticles: a review","author":"Saadh","year":"2024","journal-title":"Journal of Drug Delivery Science and Technology."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb1050","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1021\/acs.molpharmaceut.2c00528","article-title":"Modulating macrophage clearance of nanoparticles: comparison of small-molecule and biologic drugs as pharmacokinetic modifiers of soft nanomaterials","volume":"19","author":"Mills","year":"2022","journal-title":"Mol. Pharm."},{"issue":"20","key":"10.1016\/j.bioorg.2025.109202_bb1055","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.3390\/ijms232012560","article-title":"Physiologically based pharmacokinetic modeling of nanoparticle biodistribution: a review of existing models, simulation software, and data analysis tools","volume":"23","author":"Kutumova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109202_bb1060","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1166\/jbn.2017.2433","article-title":"Gelatin-encapsulated magnetic nanoparticles for pH, redox, and enzyme multiple stimuli-responsive drug delivery and magnetic resonance imaging","volume":"13","author":"Qi","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109202_bb1065","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/pharmaceutics17081074","article-title":"Anti-PEG antibodies and their biological impact on PEGylated drugs: challenges and strategies for optimization","volume":"17","author":"Fu","year":"2025","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109202_bb1070","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/acsnano.2c12193","article-title":"Antibodies against poly (ethylene glycol) activate innate immune cells and induce hypersensitivity reactions to PEGylated nanomedicines","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.bioorg.2025.109202_bb1075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/elsc.202100040","article-title":"The pro-inflammatory response of macrophages regulated by acid degradation products of poly(lactide-co-glycolide) nanoparticles","volume":"21","author":"Ma","year":"2021","journal-title":"Eng. Life Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109202_bb1080","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/10715762.2020.1859108","article-title":"Role of oxidative stress in nanoparticles toxicity","volume":"55","author":"Horie","year":"2021","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bioorg.2025.109202_bb1085","article-title":"High-density brush-shaped polymer lipids reduce anti-PEG antibody binding for repeated administration of mRNA therapeutics","volume":"1-12","author":"Xiao","year":"2025","journal-title":"Nat. Mater."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb1090","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1021\/acsnano.8b02365","article-title":"Modified magnesium hydroxide nanoparticles inhibit the inflammatory response to biodegradable poly (lactide-co-glycolide) implants","volume":"12","author":"Lih","year":"2018","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109202_bb1095","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13592","article-title":"Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity:\u201csingle\u201d vision for \u201cheterogeneous\u201d environment","volume":"57","author":"Zhang","year":"2024","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109202_bb1100","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14087","article-title":"The lipid droplet in cancer: from being a tumor-supporting hallmark to clinical therapy","volume":"240","author":"Cui","year":"2024","journal-title":"Acta Physiol."},{"key":"10.1016\/j.bioorg.2025.109202_bb1105","article-title":"Tumor acidosis supports cancer cell lipid uptake via a rapid transporter-independent mechanism","volume":"138(10):jcs263688","author":"Severin","year":"2025","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109202_bb1110","doi-asserted-by":"crossref","first-page":"2206169","DOI":"10.1002\/advs.202206169","article-title":"Emerging epigenetic-based nanotechnology for cancer therapy: modulating the tumor microenvironment","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"issue":"40","key":"10.1016\/j.bioorg.2025.109202_bb1115","doi-asserted-by":"crossref","first-page":"1902409","DOI":"10.1002\/adma.201902409","article-title":"Tumor targeting strategies of smart fluorescent nanoparticles and their applications in cancer diagnosis and treatment","volume":"31","author":"He","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioorg.2025.109202_bb1120","first-page":"1","article-title":"Nanoparticle-functionalized organoid-on-a-Chip Systems for biomedical applications","author":"Lee","year":"2025","journal-title":"Biochip J."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501082X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682501082X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T05:38:20Z","timestamp":1765863500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682501082X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":224,"alternative-id":["S004520682501082X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109202","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting lung cancer utilizing smart nanoparticles: Nanomedicine meets tumor stroma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109202","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109202"}}